Eugene Labs Pty. Ltd.
Have updates for this profile? Please contribute data
= Subscriber Access Only
You are viewing a preview of this profile. Request a Preqin Pro demo for full access to all profiles and underlying data.
With Preqin Pro, you gain an unobstructed view of all alternative asset class activity across institutional investors, fund managers, funds, portfolio companies, deals, exits, and service providers.
Eugene Labs Pty. Ltd. - overview
Established
2017
Location
Melbourne, Victoria, Australia
Primary Industry
Biotechnology
About
Founded in 2017 by its CEO, Kunal Kalro, Kate Lanyon, and CCO, Zoë Milgrom, and based in Victoria, Australia, Eugene Labs Pty. Ltd. , operates as a provider of digital genetic and health services that include various health monitoring solutions and health kits. In December 2021, Eugene Labs Pty.
Ltd. , raised USD 3. 2 million in venture funding from investor Aliavia Ventures. As of 2023, the company operates in locations like Australia and New Zealand.
Eugene offers various diagnosis solutions that include pregnancy carrier screening, proactive cancer risk tests, and proactive heart health tests for individuals and couples. The company also provides genetic testing solutions that identify changes in genes, chromosomes, and proteins. The company also provides a mobile application platform, at-home genetic testing and counselling services, in-app reports, and a referral network.
Current Investors
MedAngels, Aliavia Ventures, Flying Fox Ventures
Primary Industry
Biotechnology
Sub Industries
Biotechnology, Healthcare IT, Diagnostic Equipment
Website
www.eugenelabs.com
Verticals
HealthTech, Mobile Apps
Company Stage
Series A
Total Amount Raised
Subscriber access only
Eugene Labs Pty. Ltd. - employee data
Time to go Pro
Get Preqin Pro for unrestricted access to 600,000+ detailed profiles on fund managers, investors, funds, companies, and other alternative asset players. Unlock exclusive data on future plans, company financials, fundraising history, track records, and more.